Dechra Pharmaceuticals (DPH)

 

Latest News

Total Voting Rights

RNS Number: 8673E Dechra Pharmaceuticals PLC 14 February 2018 14 February 2018 Dechra Pharmaceuticals PLC (Dechra or the Company) LEI: 213800J4UVB5OWG8VX82 Admission of Consideration Shares and Total Voting Rights Further to the announcement of the completion of the acquisition of AST Farma B.V. and Le Vet Beheer B.V. on 13 February 2018, ...

Completion of Acquisition

RNS Number: 7888E Dechra Pharmaceuticals PLC 13 February 2018 THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED IN IT, IS RESTRICTED AND IS NOT FOR PUBLICATION, RELEASE OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, AUSTRALIA, NEW ZEALAND...

Result of General Meeting - 12 February 2018

RNS Number: 5785E Dechra Pharmaceuticals PLC 12 February 2018 THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED IN IT, IS RESTRICTED AND IS NOT FOR PUBLICATION, RELEASE OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, AUSTRALIA, NEW ZEALAND...

Broker Forecast - Numis issues a broker note on Dechra Pharmaceuticals PLC

Numis today reaffirms its add investment rating on Dechra Pharmaceuticals PLC (LON:DPH) and set its price target at 26...

All News

DateHeadlineSource
29-12-17Total Voting RightsRNS
14-12-17Holding(s) in CompanyRNS
30-11-17Total Voting RightsRNS
31-10-17Total Voting RightsRNS
20-10-17Result of AGM - 20 October 2017RNS
20-10-17Top smaller companies thriving overseasInteractive Investor
20-10-17Dechra sees continued growth across all markets StockMarketWire
20-10-17Pre Annual General Meeting StatementRNS
18-10-17Holding(s) in CompanyRNS
12-10-17Director/PDMR ShareholdingRNS
12-10-17Additional ListingRNS
04-10-17Holding(s) in CompanyRNS
02-10-17Total Voting RightsRNS
20-09-17Director Deals - Dechra Pharmaceuticals PLC (DPH)StockMarketWire
20-09-17Director Deals - Dechra Pharmaceuticals PLC (DPH)StockMarketWire
20-09-17Director/PDMR ShareholdingRNS
19-09-17Director Deals - Dechra Pharmaceuticals PLC (DPH)StockMarketWire
19-09-17Director Deals - Dechra Pharmaceuticals PLC (DPH)StockMarketWire
19-09-17Director/PDMR ShareholdingRNS
19-09-17Annual Financial ReportRNS
15-09-17BLOCK LISTING SIX MONTHLY RETURNRNS
08-09-17Broker Forecast - Cantor Fitzgerald issues a broker note on Dechra Pharmaceuticals PLCStockMarketWire
06-09-17Additional ListingRNS
05-09-17Broker Forecast - Jefferies International issues a broker note on Dechra Pharmaceuticals PLCStockMarketWire
05-09-17Availability of 2017 Annual Report and AccountsRNS
04-09-17Director Deals - Dechra Pharmaceuticals PLC (DPH)StockMarketWire
04-09-17Director/PDMR ShareholdingRNS
04-09-17Preliminary Results Announcement -year end 30.6.17RNS
31-08-17Total Voting RightsRNS
17-08-17Holding(s) in CompanyRNS
11-08-17Expert picks these winning shares for the Brexit eraMoney Observer
31-07-17Total Voting RightsRNS
25-07-17Holding(s) in CompanyRNS
06-07-17Dechra growth driven by core portfolio StockMarketWire
06-07-17Trading Update & Notice of Annual ResultsRNS
30-06-17Total Voting RightsRNS
22-06-17Director Deals - Dechra Pharmaceuticals PLC (DPH)StockMarketWire
22-06-17Director/PDMR ShareholdingRNS
31-05-17Total Voting RightsRNS
18-05-17Holding(s) in CompanyRNS

RSS feeds

  • Editorial news feed for LSE:DPH Editorial
  • Regulatory news feed for LSE:DPH Regulatory

Join interactive investor

  • £22.50 fixed quarterly charge includes £22.50 in trading credits
  • £10 per trade or £6 for frequent traders
  • No % platform fees
  • £1 per trade for regular investment or dividend reinvestment

Open an account